SE8502950L - Ny galenisk retardform - Google Patents

Ny galenisk retardform

Info

Publication number
SE8502950L
SE8502950L SE8502950A SE8502950A SE8502950L SE 8502950 L SE8502950 L SE 8502950L SE 8502950 A SE8502950 A SE 8502950A SE 8502950 A SE8502950 A SE 8502950A SE 8502950 L SE8502950 L SE 8502950L
Authority
SE
Sweden
Prior art keywords
matrix
retard form
new galenic
percent
weight
Prior art date
Application number
SE8502950A
Other languages
Unknown language ( )
English (en)
Other versions
SE8502950D0 (sv
SE504583C2 (sv
Inventor
W Czarnecki
J C Gfeller
H P Bier
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8502950D0 publication Critical patent/SE8502950D0/sv
Publication of SE8502950L publication Critical patent/SE8502950L/sv
Publication of SE504583C2 publication Critical patent/SE504583C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8502950A 1984-06-14 1985-06-13 Ny galenisk retardform SE504583C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (3)

Publication Number Publication Date
SE8502950D0 SE8502950D0 (sv) 1985-06-13
SE8502950L true SE8502950L (sv) 1985-12-15
SE504583C2 SE504583C2 (sv) 1997-03-10

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502950A SE504583C2 (sv) 1984-06-14 1985-06-13 Ny galenisk retardform

Country Status (21)

Country Link
AT (1) AT391806B (sv)
AU (2) AU587190B2 (sv)
BE (1) BE902626A (sv)
CA (1) CA1264441A (sv)
CY (1) CY1635A (sv)
DE (1) DE3520184C2 (sv)
DK (1) DK167649B1 (sv)
ES (1) ES8702141A1 (sv)
FR (1) FR2565822B1 (sv)
GB (3) GB2160100B (sv)
GR (1) GR851430B (sv)
HK (1) HK25192A (sv)
HU (1) HU198844B (sv)
IE (1) IE58834B1 (sv)
IL (1) IL75490A0 (sv)
IT (1) IT1200080B (sv)
LU (1) LU85946A1 (sv)
NL (1) NL194389C (sv)
NZ (1) NZ212390A (sv)
PT (1) PT80635B (sv)
SE (1) SE504583C2 (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
CA2231195C (en) 1996-07-08 2003-01-21 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
AU5483600A (en) * 1999-06-11 2001-01-02 Jean A. Chmielewski Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
MXPA02001267A (es) * 1999-08-04 2002-08-12 Yamanouchi Pharma Co Ltd Composicion farmaceutica estable para uso oral.
JP3893058B2 (ja) 1999-09-30 2007-03-14 ペンウェスト ファーマシューティカルズ カンパニー 高度に可溶性の薬物のための徐放性マトリックス系
US20040067256A1 (en) * 2001-02-13 2004-04-08 Anne Juppo Novel modified release formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (de) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8956602B2 (en) 2006-12-05 2015-02-17 Landec, Inc. Delivery of drugs
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
EP2334287A4 (en) 2008-08-20 2013-12-25 Univ Texas HOT EXTRUSION OF MODIFIED RELEASE MULTIPARTICLES

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (de) * 1967-11-17 1971-03-25 Beiersdorf Ag Verfahren zur Herstellung von Arzneimitteln mit verzoegerter Wirkstoffabgabe in Form von Kapseln
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
DE2549740A1 (de) * 1975-11-17 1977-05-18 Sandoz Ag Neue galenische formen und verfahren zu deren herstellung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
AU587190B2 (en) 1989-08-10
GB2196852B (en) 1989-05-17
IE851460L (en) 1985-12-14
GB8727056D0 (en) 1987-12-23
NZ212390A (en) 1992-02-25
DE3520184C2 (de) 1997-03-13
HK25192A (en) 1992-04-10
PT80635A (en) 1985-07-01
GB8514855D0 (en) 1985-07-17
CA1264441A (en) 1990-01-16
SE8502950D0 (sv) 1985-06-13
ATA174885A (de) 1990-06-15
GR851430B (sv) 1985-11-25
GB2196851A (en) 1988-05-11
IL75490A0 (en) 1985-10-31
AU4348685A (en) 1985-12-19
ES544075A0 (es) 1987-01-01
FR2565822A1 (fr) 1985-12-20
GB2160100B (en) 1989-06-01
ES8702141A1 (es) 1987-01-01
AT391806B (de) 1990-12-10
SE504583C2 (sv) 1997-03-10
IT1200080B (it) 1989-01-05
PT80635B (pt) 1987-10-20
DK264785A (da) 1985-12-15
AU4454389A (en) 1990-03-22
GB8727055D0 (en) 1987-12-23
NL8501578A (nl) 1986-01-02
BE902626A (fr) 1985-12-10
LU85946A1 (fr) 1986-01-24
GB2160100A (en) 1985-12-18
IT8548210A0 (it) 1985-06-13
NL194389B (nl) 2001-11-01
HU198844B (en) 1989-12-28
HUT40918A (en) 1987-03-30
GB2196851B (en) 1989-06-07
GB2196852A (en) 1988-05-11
DK167649B1 (da) 1993-12-06
CY1635A (en) 1992-11-06
IE58834B1 (en) 1993-11-17
NL194389C (nl) 2002-03-04
FR2565822B1 (fr) 1989-02-17
DK264785D0 (da) 1985-06-12
DE3520184A1 (de) 1985-12-19

Similar Documents

Publication Publication Date Title
SE8502950L (sv) Ny galenisk retardform
SE8603582D0 (sv) Komposition innehallande l-dopa
EP0290442A4 (en) MEDICINAL PREPARATIONS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS.
EG15458A (en) Improvements in or relating to 3-aryloxy-3-phenylpropylamines
NL300136I2 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
SE8701348D0 (sv) Improvements in pharmaceutically acceptable salts
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
SE8700137L (sv) Diuretisk komposition
ATE59294T1 (de) Stabilisierte arzneimittel.
ES8704177A1 (es) Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas.
IT8321497A0 (it) Derivati dell'ossalodidinone-2n-arilato otticamente attivi, inibitori specifici e reversibili della monoammino ossidasi di tipo b e loro procedimento di preparazione.
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
ATE41602T1 (de) Parenterale zusammensetzung.
KR890700028A (ko) 약제학적 활성화합물 및 이의 혼합물, 유기조성물 및 금속염
ATE31076T1 (de) Feste, stark alkalische, aktivchlorhaltige mittel.
MY102425A (en) Preservative for wood
ATE16568T1 (de) Aminoxid-formulierungen.
SE1214315T3 (sv)
MY101902A (en) Novel galenical retard form
ATE171951T1 (de) Amylin muteine
Senczuk et al. Toxicodynamic properties of toluidines. Part V. Methaemoglobin-genic action of toluidines.
CS274751B2 (en) Agent for plants' medium stress factors effects protection
IT1224404B (it) Composti attivi sul sistema cardiovascolare
IT7949944A0 (it) Derivati di dossorubicina dotati di attivita' antitumorale procedimento per la loro preparazione e composizioni che li contengono
SU1469946A1 (ru) Состав для обработки призабойной зоны пласта

Legal Events

Date Code Title Description
NUG Patent has lapsed